Shares of Mobile-health Network Solutions (MNDR) are up 21.3% Wednesday after the company revealed a non-binding memorandum of understanding with Hector Capital Holdings. The MOU outlines a $119 million strategic framework to acquire BIMA and M&M Helix, with the goal of expanding AI-powered healthcare services across Asia and Africa.
The deal is still very much in the early stages. Management says the combination would leverage MNDR's Nasdaq listing and operating platform alongside Hector Capital's investment and network support. But closing is subject to due diligence, independent valuation, and regulatory approvals—including Nasdaq listing rules and Singapore law. So don't count your chickens yet.
The broader market is also lending a hand. The Nasdaq is up 1.23% and the S&P 500 is up 0.81%, which gives small-cap names with fresh headlines a better chance to hold their bids.
For context, Mobile-health Network Solutions runs the MaNaDr platform—a telehealth app and website focused on doctor consultations, plus an e-commerce pharmacy store. The company reports revenue from two segments: Telemedicine and other services, and Sale of medicine and medical devices. Most of its revenue comes from Telemedicine. Geographically, it's based in Singapore, so traders often treat it as a smaller, higher-volatility health-tech name where sentiment and momentum can drive big moves.
As of premarket trading Wednesday, MNDR shares were at $1.31, up 21.3% from the previous close.
